ESC Professional Premium Access

Proprotein convertase subtilisin/kexin type 9 (PCSK9), platelet activation and interaction with the vascular endothelium: the impact of PCSK9 inhibition with evolocumab in acute coronary syndrome

Congress Session

About the speaker

Doctor Efthymios Ziogos

The Johns Hopkins University School of Medicine, Baltimore (United States of America)
0 follower

5 more presentations in this session

Lipoprotein(a) and the effect of alirocumab on coronary and non-coronary revascularization following acute coronary syndrome

Speaker: Professor P. Steg (Paris, FR)

Thumbnail

Quality matters: low-density lipoprotein electronegativity but not quantity determines mortality risk in acute coronary syndromes

Speaker: Doctor S. Kraler (Zurich, CH)

Thumbnail

Glycated haemoglobin and the association with long-term survival among patients evaluated for stable angina - a prospective Norwegian cohort

Speaker: Doctor G. Svingen (Bergen, NO)

Thumbnail

Cardioprotective effect of empagliflozin in acute myocardial infarction: the role of ketone bodies availability.

Speaker: Professor J. Badimon (New York, US)

Thumbnail

Impact of chronic GLP-1 receptor agonist and SGLT-2 inhibitor therapy on in-hospital outcomes of patients with diabetes mellitus hospitalized with acute myocardial infarction.

Speaker: Doctor F. Trombara (Milano, IT)

Thumbnail

Access the full session

What’s new on lipids and diabetes in acute coronary syndrome

Speakers: Doctor E. Ziogos, Professor P. Steg, Doctor S. Kraler, Doctor G. Svingen, Professor J. Badimon...
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

This platform is supported by

logo Novo Nordisk